SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Traws Pharma Establishes $50 Million Stock Purchase Facility

Traws Pharma may sell up to $50 million of newly issued shares over 36 months, subject to specified conditions.

TRAW

Related stories